Preventing autoimmune arthritis using antigen-specific immature dendritic cells: a novel tolerogenic vaccine |
| |
Authors: | Igor Popov Mu Li Xiufen Zheng Hongtao San Xusheng Zhang Thomas E Ichim Motohiko Suzuki Biao Feng Costin Vladau Robert Zhong Bertha Garcia Gill Strejan Robert D Inman Wei-Ping Min |
| |
Institution: | Department of Surgery, London Health Science Centre, London, Canada. |
| |
Abstract: | Conventional treatments for autoimmune diseases have relied heavily on nonspecific immune suppressants, which possess a variety of adverse effects without inhibiting the autoimmune process in a specific manner. In the present study we demonstrate the effectiveness of antigen-specific, maturation-resistant, tolerogenic dendritic cells (DC) in suppressing collagen-induced arthritis, a murine model of rheumatoid arthritis. Treatment of DC progenitors with the NF-κB inhibiting agent LF 15-0195 (LF) resulted in a population of tolerogenic DC that are characterized by low expression of MHC class II, CD40, and CD86 molecules, as well as by poor allostimulatory capacity in a mixed leukocyte reaction. Administering LF-treated DC pulsed with keyhole limpet hemocyanin antigen to naïve mice resulted hyporesponsiveness specific for this antigen. Furthermore, administration of LF-treated DC to mice with collagen-induced arthritis resulted in an improved clinical score, in an inhibited antigen-specific T-cell response, and in reduced antibody response to the collagen. The efficacy of LF-treated DC in preventing arthritis was substantiated by histological examination, which revealed a significant decrease in inflammatory cell infiltration in the joints. In conclusion, we demonstrate that in vitro-generated antigen-specific immature DC may have important potential as a tolerogenic vaccine for the treatment of autoimmune arthritis. |
| |
Keywords: | |
本文献已被 PubMed SpringerLink 等数据库收录! |
|